Kinnate Biopharma
Kinnate Biopharma Inc. Announces Recent Corporate Updates
- Form
- 8-K
- Filed
- Importance
- Routine
- Accession
- 0001140361-22-036817
- Reports quarterly results (2.02)
- Discloses other events (8.01)
Not explained yet; the original is on EDGAR.
Similar companies
Same SIC code (2834) and public float not reported.
